The Ferguson Operating Anoscope as a minimally invasive option for the treatment of rectal tumors

John Stanley, Christopher Bell, Nathan Hinkle, Richard A. Moore, R. Phillip Burns

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Transanal excision of rectal tumors may be performed using the Ferguson Operating Anoscope (FOA). This retrospective case series evaluates the effectiveness of FOA for the excision of selected benign and malignant rectal tumors. The office records of 97 patients with rectal tumors who underwent FOA transanal excision by a single surgeon from 1999 through 2009 were reviewed. In the 97 patients evaluated, 99 FOA transanal excisions were performed for 39 adenocarcinomas, 55 benign tumors, and five carcinoid tumors. The tumors were 0.5 to 13.5 cm in diameter and located an average of 6.9 cm (range, 1 to 15 cm) from the anal verge. Ninety-one per cent of cases were performed as an outpatient. Postoperative complications occurred in 14 per cent with transient effects on continence in 2 per cent and a mean blood loss of 66 mL. The recurrence rate for favorable T1 rectal cancers was 4.3 per cent and for adenomas was 5.9 per cent. In early follow up of adenomas and favorable T1 carcinomas, FOA transanal excision has similar application, morbidity, and recurrence rates as reported for transanal endoscopic microsurgery for rectal tumors within 15 cm from the anal verge. FOA may be considered a useful option for the minimally invasive treatment of rectal tumors.

Original languageEnglish (US)
Pages (from-to)850-856
Number of pages7
JournalAmerican Surgeon
Volume76
Issue number8
StatePublished - Aug 1 2010
Externally publishedYes

Fingerprint

Rectal Neoplasms
Adenoma
Therapeutics
Recurrence
Carcinoid Tumor
Neoplasms
Adenocarcinoma
Outpatients
Morbidity
Carcinoma

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

The Ferguson Operating Anoscope as a minimally invasive option for the treatment of rectal tumors. / Stanley, John; Bell, Christopher; Hinkle, Nathan; Moore, Richard A.; Burns, R. Phillip.

In: American Surgeon, Vol. 76, No. 8, 01.08.2010, p. 850-856.

Research output: Contribution to journalArticle

Stanley, J, Bell, C, Hinkle, N, Moore, RA & Burns, RP 2010, 'The Ferguson Operating Anoscope as a minimally invasive option for the treatment of rectal tumors', American Surgeon, vol. 76, no. 8, pp. 850-856.
Stanley, John ; Bell, Christopher ; Hinkle, Nathan ; Moore, Richard A. ; Burns, R. Phillip. / The Ferguson Operating Anoscope as a minimally invasive option for the treatment of rectal tumors. In: American Surgeon. 2010 ; Vol. 76, No. 8. pp. 850-856.
@article{239e0b89a42b4f698192bce3a78a7a91,
title = "The Ferguson Operating Anoscope as a minimally invasive option for the treatment of rectal tumors",
abstract = "Transanal excision of rectal tumors may be performed using the Ferguson Operating Anoscope (FOA). This retrospective case series evaluates the effectiveness of FOA for the excision of selected benign and malignant rectal tumors. The office records of 97 patients with rectal tumors who underwent FOA transanal excision by a single surgeon from 1999 through 2009 were reviewed. In the 97 patients evaluated, 99 FOA transanal excisions were performed for 39 adenocarcinomas, 55 benign tumors, and five carcinoid tumors. The tumors were 0.5 to 13.5 cm in diameter and located an average of 6.9 cm (range, 1 to 15 cm) from the anal verge. Ninety-one per cent of cases were performed as an outpatient. Postoperative complications occurred in 14 per cent with transient effects on continence in 2 per cent and a mean blood loss of 66 mL. The recurrence rate for favorable T1 rectal cancers was 4.3 per cent and for adenomas was 5.9 per cent. In early follow up of adenomas and favorable T1 carcinomas, FOA transanal excision has similar application, morbidity, and recurrence rates as reported for transanal endoscopic microsurgery for rectal tumors within 15 cm from the anal verge. FOA may be considered a useful option for the minimally invasive treatment of rectal tumors.",
author = "John Stanley and Christopher Bell and Nathan Hinkle and Moore, {Richard A.} and Burns, {R. Phillip}",
year = "2010",
month = "8",
day = "1",
language = "English (US)",
volume = "76",
pages = "850--856",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "8",

}

TY - JOUR

T1 - The Ferguson Operating Anoscope as a minimally invasive option for the treatment of rectal tumors

AU - Stanley, John

AU - Bell, Christopher

AU - Hinkle, Nathan

AU - Moore, Richard A.

AU - Burns, R. Phillip

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Transanal excision of rectal tumors may be performed using the Ferguson Operating Anoscope (FOA). This retrospective case series evaluates the effectiveness of FOA for the excision of selected benign and malignant rectal tumors. The office records of 97 patients with rectal tumors who underwent FOA transanal excision by a single surgeon from 1999 through 2009 were reviewed. In the 97 patients evaluated, 99 FOA transanal excisions were performed for 39 adenocarcinomas, 55 benign tumors, and five carcinoid tumors. The tumors were 0.5 to 13.5 cm in diameter and located an average of 6.9 cm (range, 1 to 15 cm) from the anal verge. Ninety-one per cent of cases were performed as an outpatient. Postoperative complications occurred in 14 per cent with transient effects on continence in 2 per cent and a mean blood loss of 66 mL. The recurrence rate for favorable T1 rectal cancers was 4.3 per cent and for adenomas was 5.9 per cent. In early follow up of adenomas and favorable T1 carcinomas, FOA transanal excision has similar application, morbidity, and recurrence rates as reported for transanal endoscopic microsurgery for rectal tumors within 15 cm from the anal verge. FOA may be considered a useful option for the minimally invasive treatment of rectal tumors.

AB - Transanal excision of rectal tumors may be performed using the Ferguson Operating Anoscope (FOA). This retrospective case series evaluates the effectiveness of FOA for the excision of selected benign and malignant rectal tumors. The office records of 97 patients with rectal tumors who underwent FOA transanal excision by a single surgeon from 1999 through 2009 were reviewed. In the 97 patients evaluated, 99 FOA transanal excisions were performed for 39 adenocarcinomas, 55 benign tumors, and five carcinoid tumors. The tumors were 0.5 to 13.5 cm in diameter and located an average of 6.9 cm (range, 1 to 15 cm) from the anal verge. Ninety-one per cent of cases were performed as an outpatient. Postoperative complications occurred in 14 per cent with transient effects on continence in 2 per cent and a mean blood loss of 66 mL. The recurrence rate for favorable T1 rectal cancers was 4.3 per cent and for adenomas was 5.9 per cent. In early follow up of adenomas and favorable T1 carcinomas, FOA transanal excision has similar application, morbidity, and recurrence rates as reported for transanal endoscopic microsurgery for rectal tumors within 15 cm from the anal verge. FOA may be considered a useful option for the minimally invasive treatment of rectal tumors.

UR - http://www.scopus.com/inward/record.url?scp=77956196682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956196682&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 850

EP - 856

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 8

ER -